Free Trial

Chesnara (LON:CSN) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?

Chesnara logo with Financial Services background

Shares of Chesnara plc (LON:CSN - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 255.54 ($3.34) and traded as high as GBX 265 ($3.47). Chesnara shares last traded at GBX 254.50 ($3.33), with a volume of 186,286 shares traded.

Chesnara Stock Performance

The company has a 50-day moving average price of GBX 258.67 and a two-hundred day moving average price of GBX 255.53. The company has a current ratio of 2.35, a quick ratio of 38.06 and a debt-to-equity ratio of 62.78. The stock has a market capitalization of £384.92 million, a P/E ratio of 8,500.00 and a beta of 0.44.

Chesnara Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, November 1st. Stockholders of record on Thursday, September 19th will be given a GBX 8.61 ($0.11) dividend. This represents a dividend yield of 3.27%. The ex-dividend date of this dividend is Thursday, September 19th. Chesnara's dividend payout ratio (DPR) is presently 80,000.00%.

Insider Transactions at Chesnara

In other news, insider Steve Murray bought 11,410 shares of Chesnara stock in a transaction dated Tuesday, September 10th. The stock was bought at an average cost of GBX 262 ($3.43) per share, for a total transaction of £29,894.20 ($39,123.41). Corporate insiders own 5.47% of the company's stock.

Chesnara Company Profile

(Get Free Report)

Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through UK, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products.

Featured Articles

Should you invest $1,000 in Chesnara right now?

Before you consider Chesnara, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chesnara wasn't on the list.

While Chesnara currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines